A clinical trial with two treatments of tungiasis in Homa Bay, Kenya

An existing and experimental treatment versus a local practice for tungiasis treatment: a randomized controlled trial in Homa Bay, Kenya - An existing treatment versus a local practice for tungiasis treatment: a randomized controlled trial in Kenya

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000044320

Enrollment

200

Registered

2021-05-28

Start date

2024-01-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tungiasis

Interventions

dimeticone (NYDA) for the first day 5% sodium carbonate solution for the first day

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Children who have been infected by tungiasis in Homa Bay, Kenya -Children who provide written consent to participate in the study (parental consent will also be required) -Children who have one to five embedded sand flea per foot

Exclusion criteria

Exclusion criteria: -Children with secondary bacterial infection based on the established rapid diagnostic method -Children infested with massive fleas (more than 10 fleas) -Children / Caregivers declined to participate

Design outcomes

Primary

Measure	Time frame
A difference in cure rate (embedded fleas' viability) on day 11.	—

Countries

Africa

Contacts

Public ContactKana Suzuki

Nagasaki University School of Tropical Medicine and Global Health

ksuzuki@nagasaki-u.ac.jp81958197583

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026